Loss of microRNA-145 Expression Is Involved in the Development and Prognosis of Breast Cancer Complicated by Type 2 Diabetes Mellitus

International Journal of Biological Markers- Italy

doi 10.5301/jbm.5000220

Full Text

Abstract

Available in

Date

Authors

Publisher

SAGE Publications

Related search

Effects of Fenofibrate in Patients With Type 2 Diabetes Mellitus Complicated by Diabetic Neuropathy

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Peripheral Blood microRNA-15a Is a Potential Biomarker for Type 2 Diabetes Mellitus and Pre-Diabetes

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Acute Stent Thrombosis in Myocardial Infarction Complicated by Cardiogenic Shock in the Presence of Type 2 Diabetes Mellitus

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
2018English

Platelet Inhibition by Insulin Is Absent in Type 2 Diabetes Mellitus

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2006English

HDL of Patients With Type 2 Diabetes Mellitus Elevates the Capability of Promoting Breast Cancer Metastasis

Clinical Cancer Research
Cancer ResearchOncology
2012English

Gene Expression Profile in Obesity and Type 2 Diabetes Mellitus

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2007English

Loss of Fibulin‑2 Expression Is Involved in the Inhibition of Breast Cancer Invasion and Forms a New Barrier in Addition to the Basement Membrane

Oncology Letters
Cancer ResearchOncology
2017English

Is Weight Loss the Future of Type 2 Diabetes Treatment?

Prescriber
Pharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy